Immune activation by combination human lymphokine-activated killer and dendritic cell therapy.

West, EJ orcid.org/0000-0001-7449-120X, Scott, KJ, Jennings, VA et al. (1 more author) (2011) Immune activation by combination human lymphokine-activated killer and dendritic cell therapy. British Journal of Cancer, 105 (6). pp. 787-795. ISSN 1532-1827

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2011, Cancer Research UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License
Keywords: Adaptive Immunity; Cell Line, Tumor; Cell- and Tissue-Based Therapy; Coculture Techniques; Cytokines; Cytotoxicity, Immunologic; Dendritic Cells; Humans; Immunity, Innate; Immunotherapy; Killer Cells, Lymphokine-Activated; Melanoma
Dates:
  • Published: 6 September 2011
  • Accepted: 6 July 2011
  • Published (online): 16 August 2011
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Oncology and Cancer Research - Labs (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 08 Sep 2017 12:18
Last Modified: 08 Sep 2017 12:18
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/bjc.2011.290
Related URLs:

Share / Export

Statistics